Marketing-authorisation holder · United States
Invagen Pharms
7 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BENZTROPINE MESYLATE0.5MG | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2MG | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Benzatropine | United States | Marketed | 1985 |
| BUPROPION HYDROCHLORIDE100mg | 75mg · Tablet | Bupropion | United States | Marketed | 1999 |
| LANREOTIDE ACETATE120mg base/0.5ml (eq 120mg base/0.5ml) | 60mg base/0.2ml (eq 60mg base/0.2ml) | 90mg base/0.3ml (eq 90mg base/0.3ml) · Solution | Lanreotide | United States | Marketed | 2021 |
| LEUPROLIDE ACETATE FOR DEPOT SUSPENSION22.5mg/vial · For suspension | Leuprorelin | United States | Marketed | 2018 |
| RALOXIFENE HYDROCHLORIDE60mg · Tablet | Raloxifene | United States | Marketed | 2014 |
| TROSPIUM CHLORIDE20mg · Tablet | Trospium | United States | Marketed | 2010 |
| VILAZODONE HYDROCHLORIDE10mg | 20mg | 40mg · Tablet | Vilazodone | United States | Marketed | 2019 |